U.S. Electric Utilities Stock News

AtriCure recently reported strong Q1 2026 earnings and confirmed that its BoxX-NoAF atrial fibrillation trial is running 12 months ahead of schedule, with patient enrollment now expected to be completed by the end of 2026. This faster clinical timeline, combined with momentum in its pain management segment, may tighten the feedback loop between trial outcomes, product adoption, and AtriCure’s long-term growth ambitions. Next, we’ll examine how the accelerated BoxX-NoAF enrollment timeline...

NMI Holdings (NMIH) is back in focus after recent financial updates highlighted strong capital accumulation, improved profitability from fixed cost leverage, and a 17.3% return on equity, prompting fresh scrutiny of the stock’s recent moves. See our latest analysis for NMI Holdings. The share price has firmed in the very short term, with a 1-day share price return of 1.30% and 7-day share price return of 1.81%, but is still down 10% year to date. At the same time, the 3-year total shareholder...

Lamar Advertising: Dividend Signals and Digital Growth Come Into Focus Recent commentary around Lamar Advertising (LAMR) has centered on management reaffirming full year AFFO guidance and indicating room for a higher dividend if current business trends hold. See our latest analysis for Lamar Advertising. The recent reaffirmation of full year AFFO guidance and commentary on dividend capacity arrives as the stock trades at US$151.42, with a 30 day share price return of 7.28% and a 1 year total...

If you are wondering whether Roper Technologies at around US$332 per share offers value or just reflects past enthusiasm, the starting point is to separate price moves from underlying worth. The stock is up about 2% over the past week, but remains down around 5.2% over the past month and has fallen about 23.6% year to date and 41.6% over the last 12 months, which can change how investors view both upside potential and risk. Recent coverage has focused on how software and technology companies...

Context for Telephone and Data Systems stock Telephone and Data Systems (TDS) has drawn investor attention after recent trading left the stock down about 14% over the month and about 13% over the past 3 months, in contrast with a positive 1 year total return. See our latest analysis for Telephone and Data Systems. At a share price of US$39.16, TDS has given investors a mixed ride, with shorter term share price returns weaker while the 1 year and multi year total shareholder returns remain...

FBI armor contract puts Cadre Holdings (CDRE) in focus Cadre Holdings (CDRE) is back on investor radar after subsidiary Safariland was selected as the ballistic panel provider for Predictive Ballistics' Overt Armor Kit under a five year, $61 million FBI contract. See our latest analysis for Cadre Holdings. Despite the FBI contract putting fresh attention on the business, Cadre Holdings’ share price is down 31% over the past 90 days and 27% year to date. However, the 3 year total shareholder...

DocuSign (DOCU) has kicked off Q1 2027 with total revenue of US$830.2 million and basic EPS of US$0.40, setting the stage for investors to reassess how the business is converting its top line into earnings. The company has seen quarterly revenue move from US$763.7 million in Q1 2026 to US$830.2 million in Q1 2027, while basic EPS shifted from US$0.35 to US$0.40 over the same stretch, giving you a clear read on how sales and earnings are tracking into the new fiscal year as margins come under...

A law firm has opened an investigation into Roblox (NYSE:RBLX) over potential fraud, negligence, or other unlawful practices, raising fresh questions about governance and legal risk for the platform. Separately, Roblox is overhauling its discovery algorithm to emphasize deeper user engagement and long term retention instead of immediate monetization. The company is aiming to improve content quality and appeal more to adult users. Roblox runs a global user generated gaming and experiences...

Over the past week, SEALSQ (NasdaqGS:LAES) has announced a majority stake in Wecan Group, the acquisition of Swiss photonics firm Miraex, and a lead investment role in EeroQ and Quobly funding rounds. These moves extend SEALSQ's reach across post quantum security, quantum processors, and AI driven compliance tools in both Europe and the US. The transactions are presented as completing SEALSQ's Quantum Sovereign Vertical Stack and shifting the company toward a broader quantum platform...

Recent performance snapshot for Omega Healthcare Investors Omega Healthcare Investors (OHI) has seen mixed share performance recently, with the stock up about 1.8% over the past day but down around 5% over the past week and 3% over the past month. Over longer periods, the stock shows a different pattern, with total return of about 26% over the past year and very large multiyear gains, including roughly 7x over three years and about 0.8x over five years. See our latest analysis for Omega...

Wondering if KeyCorp's share price still reflects good value after a strong run, or if most of the easy gains are behind it? This article walks through what the current valuation actually says. KeyCorp shares last closed at US$21.76, with the stock up 2.0% over the past week, slightly down 2.1% over the past month, up 3.7% year to date, and up 38.9% over the past year, while the 3 year and 5 year returns stand at 137.8% and 26.4% respectively. Recent price moves sit against a backdrop of...

ADC Therapeutics (ADCT) has drawn fresh attention after reporting statistically significant Phase 3 LOTIS-5 topline data for ZYNLONTA plus rituximab in relapsed or refractory diffuse large B cell lymphoma, including improved progression free survival versus standard therapy. See our latest analysis for ADC Therapeutics. Despite the encouraging LOTIS-5 data, the stock’s 1-day share price return fell 21.97%, extending a 7-day share price decline of 69.71% and a 1-year total shareholder return...

Keel Infrastructure (NasdaqGM:KEEL) has completed an upsized US$400 million convertible senior notes offering, above the initial US$350 million target. The transaction is intended to fund capped call arrangements and support expansion of data center projects for AI and high performance computing workloads. The offering adds financial flexibility as Keel continues its shift from Bitcoin mining toward broader digital infrastructure. Keel is positioning itself as a digital infrastructure...

For investors wondering whether Brookfield Infrastructure at around US$41.31 offers value or is asking too much for its future, this breakdown is designed to help frame that question in a clear, practical way. The stock has been slightly softer over the last week, with a 0.5% decline, but has gained 4.6% over the past month. Year to date it is down 8.8% and it is up 5.7% over the last year, with a 2.1% decline over three years and a 7.3% gain over five years. Recent price moves sit against a...

Aurinia Pharmaceuticals (NasdaqGM:AUPH) reported new AURORA 1 Phase 3 data at EULAR 2026 showing LUPKYNIS reduced the risk of renal events or death in lupus nephritis. The findings were presented at a major international rheumatology congress, putting fresh clinical evidence for LUPKYNIS in front of global specialists. Tang Capital Management increased its stake in Aurinia, and senior company executives acquired additional shares. Aurinia focuses on therapies for autoimmune kidney disease,...

Investors may be wondering if Middleby stock at around US$154.93 offers good value today, or if they are paying up mainly for the story. Over the past month the share price has risen 8.7%, while the 1-year return sits at 5.2% and the 5-year return shows a decline of 8.6%. This may hint at shifting views on both its potential and its risks. Recent coverage of Middleby has focused on its position in the capital goods space and investor interest in how its business model compares with peers...

Investors may be wondering whether IDACORP at about US$141 per share is offering good value right now, or if the easy money has already been made. The stock is up 11.0% year to date and 26.0% over the past year, although it has slipped 1.9% over the last month and inched 0.8% higher over the last week. Recent coverage has focused on IDACORP as an established electric utility, with investors weighing regulated earnings, capital needs and its role in regional power infrastructure. That...

If you are wondering whether NOV at around US$20.14 still offers value or if most of the opportunity is already priced in, you are asking the right question. The stock has returned 0.9% over the past week, is roughly flat over the last month with a 0.2% decline, and sits on a 22.7% year to date gain and 63.7% return over the past year. This naturally raises questions about how much upside or risk is now on the table. Recent coverage of NOV has focused on its role in the energy equipment and...

Coursera (COUR) released a new report indicating that 92% of US employers are willing to offer higher starting salaries to graduates with industry micro-credentials, putting the stock’s online upskilling focus back in the spotlight. See our latest analysis for Coursera. The latest employer survey lands against a tougher backdrop for shareholders, with Coursera’s share price down 22.74% year to date and the 1 year total shareholder return down 38.75%, suggesting weak recent momentum despite...

ChronoScale (NasdaqCM:CHRN) has expanded its executive team with senior hires from leading AI and technology firms. Raj Jegannathan, formerly a Vice President responsible for AI infrastructure at Tesla, has joined ChronoScale. Lawrence Lam, a veteran in global cloud and AI platforms, has also been appointed to a leadership role. The company states that these appointments are intended to accelerate the expansion of its AI infrastructure platform. For investors tracking AI infrastructure,...

Wondering whether Arthur J. Gallagher at around US$216 per share still stacks up as good value, or if the recent price action has changed the picture. The stock has risen 7.5% over the past week and 9.8% over the past month, yet is still down 15.6% year to date and has fallen 33.5% over the past year. This may prompt questions about whether expectations or perceived risk have shifted. Recent coverage around Arthur J. Gallagher has focused on its position within the insurance sector and how...

In May 2026, Trinity Capital completed a US$297.54 million fixed-income offering and announced a US$300.00 million follow-on equity raise, alongside first-quarter revenue of US$90.13 million versus US$65.39 million a year earlier and a slight dip in earnings per share. Insider share purchases during this period highlight management’s confidence in the business, even as the company continues to rely on external capital to fund its growth. We’ll now examine how Trinity’s recent fixed-income...

Bancorp (TBBK) is back in focus after recent commentary on potential Federal Reserve rate hikes raised questions about funding costs, net interest margins, and exposure to commercial real estate across regional bank portfolios. See our latest analysis for Bancorp. At a share price of US$54.11, Bancorp has seen its 1 month share price return fall 10.55% and its year to date share price return decline 20.03%. This is occurring even though the 1 year total shareholder return is 3.66% and the 5...

Why Kodiak Sciences Stock Is Back in Focus After GLOW2 Results Kodiak Sciences (KOD) is drawing fresh attention after reporting positive top line Phase 3 GLOW2 data for Zenkuda in diabetic retinopathy, which has prompted accelerated regulatory plans and renewed interest in its ophthalmology pipeline. See our latest analysis for Kodiak Sciences. The GLOW2 data initially helped extend Kodiak Sciences’ strong multi year run, with the 1 year total shareholder return now very large relative to the...